Lymphogranuloma venereum pathophysiology: Difference between revisions
(Created page with "{{Lymphogranuloma venereum}} {{CMG}} ==Overview== ==Transmission== LGV is passed from person to person through direct contact with lesions, ulcers or other area where the ba...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Lymphogranuloma venereum}} | {{Lymphogranuloma venereum}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
==Pathophysiology== | |||
==Transmission== | ===Transmission=== | ||
LGV is passed from person to person through direct contact with lesions, ulcers or other area where the bacteria is located. Transmission of the organism occurs during sexual penetration (vaginal, oral, or anal) and may also occur via skin to skin contact. The likelihood of LGV infection following an exposure is unknown, but it is considered less infectious than some other STDs. A person who has had sexual contact with a LGV-infected partner within 60 days of symptom onset should be examined, tested for urethral or cervical chlamydial infection, and treated with doxycycline, twice daily for 7 days. | LGV is passed from person to person through direct contact with lesions, ulcers or other area where the bacteria is located. Transmission of the organism occurs during sexual penetration (vaginal, oral, or anal) and may also occur via skin to skin contact. The likelihood of LGV infection following an exposure is unknown, but it is considered less infectious than some other STDs. A person who has had sexual contact with a LGV-infected partner within 60 days of symptom onset should be examined, tested for urethral or cervical chlamydial infection, and treated with doxycycline, twice daily for 7 days. | ||
== | ==Sources== | ||
[http://www.cdc.gov/std/lgv/STDFact-LGV.htm CDC LGV] | [http://www.cdc.gov/std/lgv/STDFact-LGV.htm CDC LGV] | ||
| Line 13: | Line 14: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Sexually transmitted diseases]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Needs overview]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 19:16, 21 November 2012
|
Lymphogranuloma venereum Microchapters |
|
Differentiating Lymphogranuloma venereum from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphogranuloma venereum pathophysiology On the Web |
|
American Roentgen Ray Society Images of Lymphogranuloma venereum pathophysiology |
|
Risk calculators and risk factors for Lymphogranuloma venereum pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pathophysiology
Transmission
LGV is passed from person to person through direct contact with lesions, ulcers or other area where the bacteria is located. Transmission of the organism occurs during sexual penetration (vaginal, oral, or anal) and may also occur via skin to skin contact. The likelihood of LGV infection following an exposure is unknown, but it is considered less infectious than some other STDs. A person who has had sexual contact with a LGV-infected partner within 60 days of symptom onset should be examined, tested for urethral or cervical chlamydial infection, and treated with doxycycline, twice daily for 7 days.